Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
Drug industry analysts on Monday applauded Eli Lilly and Co.’s pending $8 billion cash deal to buy a startup that focuses on oncology, which has become a prime focus for the pharma giant in the last year.
After conducting a national search, the black liberal arts college on Indianapolis’ east side has hired a diversity and inclusion officer at UIndy to replace outgoing leader Eugene White.
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Foamcraft Inc., an Indianapolis-based foam-products manufacturer than began selling mattresses less than two years ago, plans to compete directly with online mattress behemoths such as Casper, Leesa and Purple.
The YMCA of Greater Indianapolis is staying in the organization’s extended family in replacing retiring leader Eric Ellsworth, who presided over explosive growth.
As Fishers charges ahead with converting the Nickel Plate Railroad into a pedestrian pathway, the trail through Noblesville doesn’t seem to be gaining that same traction.
While we are glad to see the current efforts to spruce up the 23-year-old mall, it will continue to decline without a new master plan that shifts much of the space to alternative uses, such as office and residential.
Educators and advocates are pushing state leaders to take action this year to raise teacher compensation—not to wait for additional research, as Indiana Gov. Eric Holcomb proposed last week.
Craig Jackson, who took over executive leadership of Indianapolis Power & Light in February as part of a corporate restructuring by parent AES Corp., plans to resign at the end of the month.
